Risk factor
Strong & resilient to price shocks
Profitability factor
Strong margins and returns
About
Dottikon Es Holding AG engages in the manufacture and sale of performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also provides Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries. In addition, the company is involved in recycling, thermal recovery, and high-temperature incineration of waste streams, as well as wastewater treatment and purification activities; and provision of consulting services for investment companies, and software and engineering services. Dottikon Es Holding AG was founded in 1913 and is headquartered in Dottikon, Switzerland. Dottikon Es Holding AG is a subsidiary of EVOLMA Holding AG.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Target Price
The average target price of DESN.SW is 430 and suggests 20% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr